$TLOG #3 TetraLogic Pharmaceuticals Corporation Announces Completion of Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB
GlobeNewswire - Thu Dec 29, 9:30AM CST
TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG) ("TetraLogic" or "Company" and its wholly-owned subsidiary TetraLogic Research and Development Corporation ("TDRC" today announced that they have...
TLOG : 0.0425 (-15.67%) MVRBF : 10.1000 (+1.00%)
(0)
(0)
TetraLogic Pharmaceuticals Corporation (TLOG) Stock Research Links